Skip to content

Evaluation of a Yoga Intervention for Post-Traumatic Stress Disorder

Evaluation of a Yoga Intervention for Post-Traumatic Stress Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00962403
Acronym
EYIPTSD
Enrollment
108
Registered
2009-08-20
Start date
2009-08-31
Completion date
2012-05-31
Last updated
2013-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Stress Disorder

Keywords

post traumatic stress disorder, yoga, meditation, military, veteran, trauma, stress, depression, anxiety, insomnia, autonomic

Brief summary

The main objective of this preliminary randomized controlled clinical trial is to establish efficacy and feasibility of a yoga-based treatment for PTSD in military veterans as compared to a delayed yoga treatment (waitlist control) group. Secondary objectives are to evaluate PTSD characteristics that may also be improved with the treatment and acceptability and compliance with the treatment.

Detailed description

Specific Aims: 1. To evaluate the hypothesis that a 10-week yoga-based intervention will reduce PTSD severity to a statistically and clinically significant degree relative to a pretreatment baseline evaluation and to a waitlist control group. 2. To evaluate the hypothesis that PTSD patients will show improvement in regulation of physiological arousal in the autonomic nervous system relative to pretreatment. 3. To evaluate that hypothesis that symptoms associated with PTSD such as depression, anxiety, insomnia and quality of life will also be improved. 4. To evaluate the hypothesis that military veterans with PTSD can be successfully recruited into a yoga intervention study and will find the intervention acceptable and tolerable and will exhibit high compliance.

Interventions

BEHAVIORALYoga treatment

The 10-week Kripalu-style yoga treatment will consist of 20 biweekly 90-minute group training/practice sessions. In addition, subjects will also receive CD's and written instructions for the daily 15-minute sessions, which they will use to guide them through the yoga procedures to be done at home.

Sponsors

United States Department of Defense
CollaboratorFED
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and female military veterans and active duty military personnel aged 18 and older * A DSM IV diagnosis of post-traumatic stress disorder * Potential subjects on medications are eligible to participate in the study * Potential subjects who receive ongoing medical or psychological treatment are eligible to participate in this study as long as these treatments do not include more than one hour weekly of relaxation and mind-body based stress reduction strategies (strategies directly related to meditation and yoga) * Potential subjects are eligible to participate in this study if they have sufficient mental and physical ability to fully participate in the parameters of the study. Subjects must be able to understand and comply with instructions in the group yoga sessions and home practice, complete questionnaires, participate in clinical interviews, and take part in all data collection activities. Subjects with severe mental or physical concerns that may prevent them from understanding and/or complying with the treatment will be excluded. For example, potential subjects confined to wheelchairs will not be eligible, although subjects with artificial limbs who are able to reasonably participate in the intervention may be deemed eligible. These determinations will be made during discussions with potential subjects on a case by case basis during the screening process

Exclusion criteria

* Potential subjects are ineligible if pregnant and in their third trimester. * Potential subjects are ineligible if they are confined to a wheel chair.

Design outcomes

Primary

MeasureTime frame
Clinician Administered PTSD Scale (CAPS)pre-intervention and 10 weeks

Secondary

MeasureTime frame
PTSD Checklist Military Version (PCL-M)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Impact of Events Scale - Revised (IES-R)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
25-item Resilience Scale (RS)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Twenty-four-hour urinary samplespre-intervention and 3 months post intervention
10-minute segment of a seated 30-minute electrocardiogram recording sessionpre-intervention and 3 months post intervention
Beck Depression Inventory (BDI)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Spielberger State Trait Anxiety Inventory (STAI)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Daily Sleep Wake Diariesduring intervention (weeks 1-10) and 3 months post intervention
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Credibility Expectancy Questionnaire (CEQ)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Body-Oriented State Questionnaire (BOSC)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
5-Facet Mindfulness Questionnaire (FFMQ)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Perceived Stress Scale (PSS)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention
Yoga Follow-up Questionnaire3 months post intervention
PTSD Checklist Civilian Version (PCL-C)pre-intervention, 5 weeks, 10 weeks and 3 months post intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026